Conversely, deletion or down-regulation of ING4 is firmly associated with high tumor grade, metastasis, and poor prognosis in a number of cancers, including breast carcinoma [16], glioblastoma [8] and gastric carcinoma [17]. Here, ING4 is linked to neoplasm.